SC 13D

Company

Verrica Pharmaceuticals Inc.

Filed

July 15, 2022

Accession Number

0001104659-22-080215

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →